Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
JTO CLINICAL AND RESEARCH REPORTS
Journal
Overview
Identity
Other
View All
Overview
publication venue for
Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced ALK-Positive NSCLC
. 3.
2022
Identity
Electronic International Standard Serial Number (EISSN)
2666-3643
Other
journal abbreviation
JTO CLIN RES REP